Trials / Unknown
UnknownNCT03953365
Prophylactic Mesh in Cytoreductive Surgery
Prevention of Incisional Hernia With Prophylactic Mesh in Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy. A Multicentre, Prospective, Randomised Controlled Trial
- Status
- Unknown
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 66 (estimated)
- Sponsor
- Hospital Universitario Fundación Alcorcón · Academic / Other
- Sex
- All
- Age
- 18 Years – 75 Years
- Healthy volunteers
- Not accepted
Summary
Evaluate the effectiveness of mesh reinforcement in high-risk patients to prevent incisional hernia.
Detailed description
Based on the hypothesis that oncological cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy (HIPEC) is associated with an increased risk of developing Incisional Hernia in the postoperative period, with an expected incidence of 50% at 24 months, we designed a prospective, multicenter and randomized clinical study to demonstrate the utility of the meshes in the prevention of Incisional Hernia, hoping to reduce the incidence to 15% at 24 months.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | Prophylactic Mesh | Prophylactic Mesh after closure of the abdominal wall after Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy |
Timeline
- Start date
- 2019-06-01
- Primary completion
- 2021-05-31
- Completion
- 2023-12-31
- First posted
- 2019-05-16
- Last updated
- 2019-05-16
Source: ClinicalTrials.gov record NCT03953365. Inclusion in this directory is not an endorsement.